INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 24 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,438,070 | +1.5% | 1,452,332 | -0.3% | 0.00% | – |
| Q4 2022 | $1,417,271 | -12.2% | 1,457,332 | -13.2% | 0.00% | – |
| Q3 2022 | $1,615,000 | -60.0% | 1,678,000 | -60.1% | 0.00% | -100.0% |
| Q2 2022 | $4,035,000 | +37.2% | 4,203,000 | +30.6% | 0.00% | – |
| Q1 2022 | $2,941,000 | -19.0% | 3,218,000 | -16.7% | 0.00% | – |
| Q4 2021 | $3,633,000 | -56.1% | 3,862,000 | -57.6% | 0.00% | -100.0% |
| Q3 2021 | $8,277,000 | -18.4% | 9,102,000 | -20.8% | 0.00% | 0.0% |
| Q2 2021 | $10,142,000 | +7.9% | 11,490,000 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $9,396,000 | -14.9% | 11,452,334 | -20.8% | 0.00% | -50.0% |
| Q4 2020 | $11,040,000 | -12.7% | 14,464,000 | -7.2% | 0.00% | 0.0% |
| Q3 2020 | $12,651,000 | -2.2% | 15,592,000 | -8.6% | 0.00% | -33.3% |
| Q2 2020 | $12,934,000 | +4.4% | 17,062,000 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $12,394,000 | -21.0% | 15,285,000 | -2.9% | 0.00% | -25.0% |
| Q4 2019 | $15,684,000 | +7.9% | 15,746,000 | -6.4% | 0.00% | 0.0% |
| Q3 2019 | $14,538,000 | -25.7% | 16,815,000 | -23.3% | 0.00% | -20.0% |
| Q2 2019 | $19,563,000 | +73.4% | 21,919,000 | +92.3% | 0.01% | +66.7% |
| Q1 2019 | $11,283,000 | -15.6% | 11,396,000 | -22.3% | 0.00% | -25.0% |
| Q4 2018 | $13,374,000 | +43.9% | 14,658,000 | +59.4% | 0.00% | +100.0% |
| Q3 2018 | $9,292,000 | +39.1% | 9,195,000 | +19.0% | 0.00% | 0.0% |
| Q2 2018 | $6,680,000 | +12.4% | 7,727,000 | +3.6% | 0.00% | 0.0% |
| Q1 2018 | $5,944,000 | +1.4% | 7,457,000 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $5,863,000 | +2.4% | 7,376,000 | -0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,727,000 | -20.0% | 7,377,000 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $7,155,000 | +37.4% | 7,367,000 | +33.6% | 0.00% | +100.0% |
| Q1 2017 | $5,206,000 | +7.2% | 5,516,000 | +1.4% | 0.00% | 0.0% |
| Q4 2016 | $4,858,000 | – | 5,442,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|